Fundraising FoxEmmeline Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Osteoboost is an FDA-cleared, drug-free prescription device that uses precision vibration therapy to slow bone density and strength loss in postmenopausal women with osteopenia.
Digital HealthFemTechMedical Devices
Dan Burnett(Co-Founder)inMichael Jaasma(Chief Scientific Officer and Co-Founder)inShane Mangrum(Co-Founder)inLaura Yecies(Chief Executive Officer & President)inPamela M. Peeke(Chief Medical Officer)in
Co-investorsEsplanade VenturesAmbit Health VenturesBand of AngelsGolden SeedsGood Growth CapitalHealthtech Capital+3 more
Prickly Pear is an AI health companion app designed for women in their 30s–50s that uses voice analysis to detect emotional patterns and hormonal shifts impacting brain health and mental clarity.
AI & Machine LearningDigital HealthFemTech
Co-investorsAZ Venture Capital Inc.Copper Sky Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.